Can-Fite BioPharma American Depositary Shares
CANF
6 hedge funds and large institutions have $434K invested in Can-Fite BioPharma American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
173% more capital invested
Capital invested by funds: $159K → $434K (+$275K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
33% less funds holding
Funds holding: 9 → 6 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$193K |
| 2 |
VF
Virtu Financial
New York
|
+$110K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.1K |
| 4 |
Morgan Stanley
New York
|
+$23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$25K |
| 2 |
Mercer Global Advisors
Denver,
Colorado
|
-$24K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$21K |
| 4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $212K | +$193K | +529 | +814% |
|
|
VF
2
Virtu Financial
New York
| $132K | +$110K | +302 | +444% |
|
|
SFI
3
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $31K | – | – | – |
|
|
4
Morgan Stanley
New York
| $31K | +$23K | +63 | +252% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $27K | +$28.1K | +77 | New |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $949 | – | – | – |
|
|
7
Envestnet Asset Management
Chicago,
Illinois
| – | -$25K | -71 | Closed |
|
|
8
Mercer Global Advisors
Denver,
Colorado
| – | -$24K | -69 | Closed |
|
|
9
Citadel Advisors
Miami,
Florida
| – | -$21K | -59 | Closed |
|
|
GWM
10
Geneos Wealth Management
Englewood,
Colorado
| – | -$1K | -3 | Closed |
|
CANF Hedge Fund Activity: Q4 2020 in Review
6 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2020, worth a combined $434K — up 173% from $159K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CANF and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $193K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $25K sold.
- 6 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2020, down from 9 in Q3 2020.
- Funds reported $434K of Can-Fite BioPharma American Depositary Shares stock for Q4 2020, up 173% quarter-over-quarter.
- 1 fund opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2020 and 4 closed out, a net change of -3 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2020 was Renaissance Technologies, an estimated $193K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2020 was Envestnet Asset Management, an estimated $25K sold.
Based on aggregated 13F filings for Q4 2020.